Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
E-pub ahead of print

Molecular heterogeneity of pancreatic intraductal papillary mucinous neoplasms and implications for novel endoscopic tissue sampling strategies

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prolonging fixation time of an alternative fixative to formalin for dermatological samples using standard laboratory protocols

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Predictive value of AZGP1 following radical prostatectomy for prostate cancer: a cohort study and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Plasma levels of intact and cleaved urokinase plasminogen activator receptor (uPAR) in men with clinically localised prostate cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Prevalence of human papillomavirus in squamous cell carcinomas of the soft palate

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. ERG protein expression over time from diagnostic biopsies to radical prostatectomy specimens in clinically localised prostate cancer.

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Pancreatic surgery during the COVID-19 pandemic 2020-2021: an observational cohort study from a third level referral center

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Letter to the Editor. Copenhagen grading of meningioma

    Research output: Contribution to journalLetterResearchpeer-review

  4. Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

AIMS: Intraductal papillary mucinous neoplasms (IPMNs) may be precursor lesions of pancreatic cancer. The path towards malignancy is associated with mutations in tumour suppressor-and oncogenes that may serve as biomarkers during diagnostic investigation. A novel micro forceps has made it possible to obtain biopsies from the cyst wall for analysis by next generation sequencing (NGS), providing an opportunity for early detection and intervention. However, the impact of spatial tumour heterogeneity on the representability of the biopsies has not been determined. The primary aim is to characterise the impact of molecular heterogeneity of the luminal cyst wall on tissue sampling strategies with small biopsies.

METHODS: We performed NGS and immunohistochemical phenotyping on 18 resected IPMNs with varying degrees of dysplasia and for a subset, concomitant carcinoma, using a commercially available NGS-panel of 51 oncogenes. We simulated endoscopic biopsies by performing punch biopsies (PBs) of the cyst wall from resected specimens.

RESULTS: In total, 127 NGS analyses were performed. Concomitant KRAS and GNAS was a common feature of the IPMNs. Mutations in KRAS and GNAS were associated with low-grade dysplasia whereas alterations in TP53, SMAD4, CDKN2A and PIK3CA were associated with high-grade dysplasia and/or carcinoma. The mutational analysis of the PBs from the cyst wall was compared with the whole lesion. No difference was detected between PBs and whole lesions when the cumulated mutational profile in increasing order of randomly performed PBs was compared.

CONCLUSIONS: Small IPMN biopsies from the cyst wall are adequate to yield a molecular diagnosis.

Original languageEnglish
JournalJournal of Clinical Pathology
ISSN0021-9746
DOIs
Publication statusE-pub ahead of print - 2022

Bibliographical note

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

    Research areas

  • diagnostic techniques and procedures, molecular, pancreas, pancreatic neoplasms, pathology

ID: 70950321